Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class I Ongoing · initiated 2025-07-30

Microbial Contamination of Sterile Products: elevated endotoxin levels

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

GenoGenix LLC

US Class II Ongoing · initiated 2025-07-30

Lack of Assurance of Sterility

Pfizer

US Class II Ongoing · initiated 2025-07-29

Subpotent drug

Amerisource Health Services LLC

US Class II Ongoing · initiated 2025-07-29

CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot assure that prod…

Fucidin tablet 250mg

Canada Type II Ongoing · initiated 2025-07-29

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

EPINEPHRINE INJECTION USP, SODIUM BICARBONATE INJECTION USP & DEXTROSE INJECTION USP

Canada Type I Ongoing · initiated 2025-07-28

Contamination. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Alembic Pharmaceuticals Limited

US Class II Ongoing · initiated 2025-07-25

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.